首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1524242

勃起功能障碍设备市场- 按设备类型（非手术设备、手术设备）、按年龄组（<40、40 -60 岁、>60）、按原因（糖尿病、神经系统疾病、高血压）、依最终用途（医院、诊所、ASC）及预测，2024 - 2032 年

Erectile Dysfunction Device Market - By Device Type (Non-Surgical Devices, Surgical Devices), By Age Group (<40, 40 -60 years, >60), By Cause (Diabetes, Neurological disorders, Hypertension), By End-use (Hospitals, Clinics, ASCs) & Forecast, 2024 - 2032

出版日期: 2024年04月24日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在全球倡导团体和医疗保健提供者不断加强消除勃起功能障碍的推动下，全球勃起功能障碍设备市场在 2024 年至 2032 年间复合年增长率将超过 9.3%。透过挑战社会禁忌和促进公开对话，这些措施使男性能够毫无恐惧或羞耻地寻求必要的医疗援助。这种文化转变可以改善个人健康状况，并推动勃起功能障碍治疗市场的成长。

例如，2023 年 11 月，MangoRx 发起了一项关注男性健康意识的慈善活动。该公司承诺将整个月捐赠其品牌商品销售收入的 50%，以支持各种男性健康和保健慈善机构。

随着越来越多的男性愿意讨论自己的担忧并获得医疗保健服务，对有效解决方案（包括医疗设备和疗法）的需求也在增加。最终，消除污名化的努力在扩大勃起功能障碍治疗市场、加强整体患者护理方面发挥着至关重要的作用。

整个勃起功能障碍设备市场根据设备类型、年龄层、原因、最终用途和地区进行分类。

从2024 年到2032 年，手术器械领域的复合年增长率将令人印象深刻。。此外，手术技术和设备设计的进步改善了结果，减少了併发症并缩短了恢復时间。随着人们认识的提高和对 ED 的耻辱感的减少，越来越多的男性正在探索手术选择作为恢復性功能的可行解决方案。这一趋势得到了为患者寻求有效、持久治疗选择的医疗保健提供者的支持。

由于多发性硬化症和脊髓损伤 SCI 等可导致 ED 的疾病普遍存在，到 2032 年，神经系统疾病领域将占据显着的勃起功能障碍设备市场份额。这些患者通常需要专门的治疗，以解决影响性功能的神经方面以及实现和维持勃起的身体能力。 ED 设备提供了非侵入性或微创选项，可以整合到综合治疗计划中，为这些患者提供恢復性功能并改善生活品质的机会，儘管他们有潜在的神经系统疾病。

欧洲勃起功能障碍设备市场将显着成长，到2032 年复合年增长率有望实现。有效解决方案的需求。许多欧洲国家医疗保健基础设施和报销政策的创新使这些设备更容易被更广泛的人使用。对医疗保健和生活品质的文化态度也有所贡献，因为越来越多的男性寻求能够谨慎有效地恢復性功能的非侵入性治疗，从而促进市场成长。

产业生态系统分析
产业影响力
- 成长动力
  - 勃起功能障碍的盛行率不断增加
  - 设备技术进步
  - 意识和接受度不断提高
  - 研发投入增加
- 产业陷阱与挑战
  - 併发症的风险
成长潜力分析
监管环境
技术景观
报销场景
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按设备类型，2021 - 2032 年

主要趋势
非手术器械
- 勃起功能障碍衝击波发生器
- 真空收缩装置
- 外部阴茎刚性装置
手术器械
- 阴茎植入物
  - 充气植入物
  - 可延展植入物
- 其他手术器械

第 6 章：市场估计与预测：按年龄划分，2021 - 2032

主要趋势
少于 40
40-60岁
超过60年

第 7 章：市场估计与预测：按原因划分，2021 年 - 2032 年

主要趋势
糖尿病
神经系统疾病
高血压
其他原因

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
诊所
门诊手术中心
其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Augusta Medical Systems
Boston Scientific Corporation
Coloplast Corporation
Medispec Ltd.
MTS Medical UG
NOVAmedtek
Owen Mumford Ltd.
Promedon
SILIMED
STORZ MEDICAL AG
Zephyr Surgical Implants
Zimmer Aesthetics

简介目录

Product Code: 9193

Global Erectile Dysfunction Device Market will indicate over 9.3% CAGR between 2024 and 2032, driven by escalating efforts to destigmatize erectile dysfunction by advocacy groups and healthcare providers globally. By challenging societal taboos and promoting open dialogue, these initiatives empower men to seek necessary medical assistance without fear or shame. This cultural shift enhances individual health outcomes and fuels market growth for erectile dysfunction treatments.

For instance, in November 2023, MangoRx launched a charitable campaign focusing on mens health awareness. The company pledges to donate 50% of sales proceeds from its branded merchandise throughout the month to support various mens health and wellness charities.

As more men feel comfortable discussing their concerns and accessing healthcare services, demand rises for effective solutions, including medical devices and therapies. Ultimately, destigmatization efforts play a crucial role in expanding the market for erectile dysfunction treatments, enhancing overall patient care.

The overall erectile dysfunction device market is classified based on device type, age group, cause, end-use, and region.

The surgical devices segment will register an impressive CAGR from 2024 to 2032. Surgical devices, such as penile implants, offer a long-term solution for ED that may be preferred by patients who have not responded well to other treatments. Moreover, advancements in surgical techniques and device design have improved outcomes, reducing complications and recovery times. As awareness grows and the stigma surrounding ED diminishes, more men are exploring surgical options as a viable solution to restore sexual function. This trend is supported by healthcare providers seeking effective, durable treatment options for their patients.

The neurological disorders sector will seize a notable erectile dysfunction device market share by 2032 because of the prevalence of conditions such as multiple sclerosis MS and spinal cord injuries SCI that can lead to ED. These patients often require specialized treatments that can address both the neurological aspects affecting sexual function and the physical ability to achieve and maintain an erection. ED devices provide non-invasive or minimally invasive options that can be integrated into comprehensive treatment plans, offering these patients a chance to regain sexual function and improve their quality of life despite their underlying neurological conditions.

Europe erectile dysfunction device market will register significant growth, with a promising CAGR through 2032. Europe aging population, coupled with increasing awareness and acceptance of ED as a treatable condition, has fueled demand for effective solutions like ED devices. Innovations in healthcare infrastructure and reimbursement policies in many European countries have made these devices more accessible to a broader demographic. Cultural attitudes toward healthcare and quality of life also contribute, as more men seek out non-invasive treatments that can restore sexual function discreetly and effectively, bolstering market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of erectile dysfunction
  - 3.2.1.2 Technological advancement in devices
  - 3.2.1.3 Growing awareness and acceptance
  - 3.2.1.4 Rise in R&D investment
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Risk of complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Non-surgical devices
- 5.2.1 Erectile dysfunction shock wave generators
- 5.2.2 Vacuum constriction devices
- 5.2.3 External penile rigidity devices
5.3 Surgical devices
- 5.3.1 Penile implants
  - 5.3.1.1 Inflatable implants
  - 5.3.1.2 Malleable implants
- 5.3.2 Other surgical devices

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Less than 40
6.3. 40-60 years
6.4 More than 60 years

Chapter 7 Market Estimates and Forecast, By Cause, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Diabetes
7.3 Neurological disorders
7.4 Hypertension
7.5 Other causes

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Clinics
8.4 Ambulatory surgical centers
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa